This study aimed to show that pretreatment with oxaliplatin and MSC expressing soluble TRAIL in chemoresistant CRC cell lines increases the apoptotic effect of TRAIL and provides additional chemotherapy for resistant cancers. Here, TNFSF10 is linked to colorectal carcinoma.